Colonic Dendritic Cells, Intestinal Inflammation, and T Cell-Mediated Bone Destruction Are Modulated by Recombinant Osteoprotegerin
Open Access
- 1 December 2003
- Vol. 19 (6) , 849-861
- https://doi.org/10.1016/s1074-7613(03)00326-1
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- High prevalence of osteoporotic vertebral fractures in patients with Crohn's diseaseGut, 2002
- Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor κB ligand on adult T-cell leukemia cellsBlood, 2002
- Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of boneBone, 2001
- Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in VivoThe Journal of Experimental Medicine, 2000
- Activated T Lymphocytes Support Osteoclast Formation in VitroBiochemical and Biophysical Research Communications, 1999
- DEVELOPMENT AND MATURATION OF SECONDARY LYMPHOID TISSUESAnnual Review of Immunology, 1999
- CD40 AND CD154 IN CELL-MEDIATED IMMUNITYAnnual Review of Immunology, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene.The Journal of Experimental Medicine, 1995
- Interleukin‐2 stimulates osteoclastic activity; Increased acid production and radioactive calcium releaseJournal of Periodontal Research, 1989